Oncology Vol 27 No 10_Suppl_2

The Place of Transplantation in Mantle Cell Lymphoma

October 15, 2013

The role of transplant in MCL is in clinical evolution. Up-front high-dose therapy and autologous stem cell transplant remains an attractive option for those with chemosensitive disease regardless of the induction regimen chosen, whereas this approach in the relapsed or refractory setting has not yielded long-term disease-free intervals.

Novel Therapies in Mantle Cell Lymphoma: A Pathway to Chemotherapy-Free Strategies

October 15, 2013

This review will cover innovative therapeutic approaches in relapsed or refractory MCL, many of which have the potential to alter treatment paradigms toward the development of strategies that do not involve conventional chemotherapy agents.